BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Ruiten CC, Veltman DJ, Wijdeveld M, Ten Kulve JS, Kramer MHH, Nieuwdorp M, IJzerman RG. Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab 2022;24:1588-97. [PMID: 35491524 DOI: 10.1111/dom.14732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Blüher M. GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating. Nat Rev Endocrinol 2022. [PMID: 35821108 DOI: 10.1038/s41574-022-00722-2] [Reference Citation Analysis]